Medicxi
London · Pre-Seed–Series C · 34 people tracked
Investment thesis
Medicxi focuses on life sciences investments with deep expertise in drug discovery and therapeutics development. The firm leverages decades of experience from its founding team's background at Index Ventures. It manages portfolios across multiple funds and has backing from major pharmaceutical and healthcare entities including GlaxoSmithKline, Johnson & Johnson Innovation, Novartis, and Verily, demonstrating confidence from leading industry players in its investment strategy and capabilities.
Source: firm website, verified Jul 17, 2026.
Team · 34 people
from the firm's websiteInvestments · 5 tracked
- Centessa Pharmaceuticals
- Curevo
- Ethyreal Bio
- RAPT Therapeutics
- Vicebio
Frequently asked questions
- What stage does Medicxi invest at?
- Medicxi invests at the Pre-Seed, Seed, Series A, Series B, Series C stages.
- What sectors does Medicxi focus on?
- Medicxi focuses on Biotech, Digital Health, Medical Devices.
- Where is Medicxi located?
- Medicxi is headquartered in London, GB.
Similar investors
A deep technology venture capital firm investing in companies solving major global challenges across climate change, human health, defense, security, space, and physically intensive industries.
Osage University Partners invests in breakthrough startups emerging from leading research labs and innovation ecosystems, with a focus on tech and life science companies. The firm manages $800 million and has 150+ portfolio companies across all investment stages from pre-seed to crossover.
Third Rock Ventures is a life sciences venture capital firm focused on discovering and building transformative companies.
Innovestor is a Nordic venture capital firm founded in 2014 that invests across multiple funds targeting life science, sustainable technology, and green transition startups, alongside real estate assets. The firm operates through several vehicles including VC funds, an accelerator program, and corporate venturing services.
EQT Life Sciences, formerly known as LSP, is one of Europe's largest life sciences investors with a 30-year track record. The firm targets innovative companies developing therapeutics, medical devices, diagnostics, and healthtech solutions globally, backed by a team of experienced medical, scientific, and industry professionals.